BASF SE (BASFY) shares rallied 9.6% in the last trading session to close at $11.81. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 23.2% loss over the past four weeks.
BASFY's rally is driven by a surge in material stocks after President Trump announced he would pause reciprocal tariffs for 90 days for most countries.
This company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -17.4%. Revenues are expected to be $18.77 billion, down 1.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For BASF, the consensus EPS estimate for the quarter has been revised 4.8% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on BASFY going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
BASF is a member of the Zacks Chemical - Diversified industry. One other stock in the same industry, Compass Minerals (CMP), finished the last trading session 5.5% higher at $9.91. CMP has returned -9.3% over the past month.
For Compass , the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.39. This represents a change of -73.8% from what the company reported a year ago. Compass currently has a Zacks Rank of #3 (Hold).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BASF SE (BASFY) : Free Stock Analysis Report
Compass Minerals International, Inc. (CMP) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.